Is the third component of metabolic syndrome really predictive of outcomes in type 2 diabetic patients?
Monami
Matteo
M
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence and Azienda Ospedaliera Careggi, Via delle Oblate 4, 50134 Florence, Italy.
Lambertucci
Lorella
L
Ungar
Andrea
A
Pieri
Maria
M
Masotti
Giulio
G
Marchionni
Niccolò
N
Mannucci
Edoardo
E
D000368:Aged; D001794:Blood Pressure; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000401:mortality* / Q000628:therapy; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D015228:Hypertriglyceridemia / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis* / Q000401:mortality* / Q000628:therapy; D008875:Middle Aged; D009017:Morbidity; D011237:Predictive Value of Tests; D012042:Registries; D012307:Risk Factors